Thursday, 28 August 2014
Last updated 4 hours ago
Nov 11 2005 | 8:22pm ET
Scott Moonly has been appointed v.p. of life science investments for Brookstone Capital, which specializes in alternative investment opportunities.
Moonly, who joins the firm from L.E.K. Consulting, will be responsible for identifying life science investment opportunities and performing due diligence on both private and public companies. He holds a Ph.D. in biomedical engineering.
In addition to working at L.E.K. Consulting, Moonly has served as an investment analyst with the Merrill Lynch Healthcare Group where he provided financial and strategic analysis for biotechnology and medical device companies. Brookstone has offices in Costa Mesa, Calif. and Las Vegas.
Aug 25 2014 | 11:21am ET
As many of you know, FINalternatives was recently acquired by the owners of Futures magazine, a firm called The Alpha Pages LLC. Today marks the soft-launch of a new sister site for both publications. As its name suggests, The Alpha Pages will cover all types of alternative investments, going far beyond the more well-known ones such as hedge funds and private equity. Read more…
Commodities/Futures magazine launched at the precipice of a revolution in the futures industry—really a revolution in the idea of risk management—that would move it from a small niche industry to ...